Načítá se...
Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin
Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies might be useful for treating even severe cases of d...
Uloženo v:
| Vydáno v: | Emerg Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Centers for Disease Control and Prevention
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918160/ https://ncbi.nlm.nih.gov/pubmed/27314309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2207.151670 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|